Eyelash Extension FAQ
 

NovaLash’s adhesives are in full compliance with the FDA’s recommended maximum concentration for formaldehyde of 0.2% for cosmetics.  When using EPA method TO-11A/8315HPLC-UV, NovaLash’s adhesives do not contain any detectable formaldehyde as manufactured and delivered in the bottle.  Laboratory tests show that there is no detectable formaldehyde present in the bottle in NovaLash’s adhesives based upon a detection limit of 0.05 parts per billion or 1 nanogram per cubic meter.  When cyanoacrylate adhesives are exposed to ambient air, the formation of formaldehyde may occur, therefore, opening the bottle and performing lash extension procedures may result in the production of de minimus amounts of formaldehyde.  In an effort to minimize this potential as much as possible, NovaLash is committed to producing and delivering the purest product possible prior to the bottle being opened.

NovaLash goes to great lengths to eliminate the formation of formaldehyde in its adhesive during the manufacturing process. There are many extra steps followed to purify our adhesives. If these steps are not followed, formaldehyde can form in the bottle as a bi-product of exposure to water vapor in the air.

Once the adhesive bottle is opened for use, a de minimus amount of formaldehyde is produced. The amount of formaldehyde produced during the drying process is not a health hazard.

It is important to protect the adhesive bottle from moisture when not in use. This can be done by insuring that the cap is replaced immediately after dispensing the adhesive. Care should be taken to close the cap tightly.

The American Extended-Wear Cosmetics Association (AE-WCA) is a board of medical professionals that reviews the safety and quality/performance of products such as cosmetic tattoo pigments, lash extension adhesives and removers, and sunless tanning products. Cosmetic products like these, which are worn on the skin or hair for extended periods of time, are tested for the presence of ingredients that can be harmful to the health of both consumers and the professionals who work with them. Sophy Merszei, NovaLash company president, is proud to be the founding member of this organization and currently sits on the board of the AE-WCA. At present, the AE-WCA has a sister organization in Japan, Espoir, comprised of a beauty school and two lash salons, also instrumental in founding an organization dedicated to health and safety standards for the eyelash extension industry in Japan.
The ISO 10993 set entails a series of standards for evaluating the biocompatibility of a medical device prior to a clinical study. These documents were preceded by the Tripartite agreement and is a part of the harmonisation of the safe use evaluation of medical devices. www.iso.org

Novalash, Inc. has a patent-pending on its flexible adhesive formula for eyelash extensions.
Patent Application No.: 20080196732

Novalash, Inc. has a patent-pending on its quality control system for eyelash extensions. This special system allows consumers and professionals to rest assured that every attempt has been made to produce the finest product available.
(Patent Application No.:PCT/IB2006/001293)

 
View Before & After Photos
see how good you can look with NovaLash Eyelashes
NovaLash In the News
latest articles about NovaLash in the beauty & fashion industries top magazines
Register for a Workshop
become a NovaLash Lash Extension Specialist
Order Your NovaLash Kit
Your Salon clients should have the best in eyelash extension technology